NASDAQ$OM

Outset Medical Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Headline financials

Total Revenue

$26.3M

Previous: $13.8M+91.3%
EPS (adj)

-$0.65

Previous: -$3.44+81.1%
Capital Expenditures

-$2.26M

Previous: -$6.45M+65.0%
Free Cash Flow

-$32.7M

Previous: -$48.7M+32.9%
Net Income

-$30.5M

Previous: -$42.3M+28.0%
Operating Income

-$30.1M

Previous: -$40.7M+26.0%
Gross Profit

$2.95M

Previous: -$5.13M+157.5%
Cash & Equivalents

$231M

Previous: $311M-26.0%
Total Assets

$489M

Previous: $426M+14.7%
Stock-Based Comp

$2.86M

Previous: $13.9M-79.4%

Revenue & EPS history

Outset Medical · Revenue · Quarterly

$26.3M

Q3 2021+91.3%vs Q3 2020
Beat estimate in 8 of 10 quarters(80%)
ActualEstimate

Revenue by segment

Outset Medical · $30.4M total across 2 segments · Q3 2023

  • Product Revenue
    $23.5M
  • Service and Other Revenue
    $6.83M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-2.7%

Avg return

Earnings day

-4.8%

Avg return

5 days after

+0.5%

Avg return

30 days after

50%

12 / 24 earnings

Positive

+33.5%

Q1 2025

Best reaction

-69.6%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.2%-17.1%-2.3%
Q4 2025-16.3%-28.4%-28.3%
Q3 2025-48.6%-61.2%-64.5%
Q1 2025+33.5%+46.8%+78.3%
Q4 2024+2.1%-13.0%-28.7%
Q3 2024+23.7%+36.0%+91.4%
Q2 2024-69.6%-75.0%-86.1%
Q1 2024-13.7%-18.2%+18.7%
Q4 2023+1.8%+9.3%-40.6%
Q3 2023-13.6%-13.8%+33.7%
Q2 2023-14.6%-17.5%-31.8%
Q1 2023+8.3%+3.4%+15.4%
Q4 2022-6.5%-10.6%-30.5%
Q3 2022+20.2%+44.2%+82.5%
Q2 2022+21.8%+23.5%+18.4%
Q1 2022-13.2%-38.5%-39.5%
Q4 2021+9.5%+15.9%+22.6%
Q3 2021-0.1%-4.6%-22.9%
Q2 2021-2.5%-9.9%+21.1%
Q1 2020-5.6%-14.4%-16.7%
Q1 2021-9.1%-11.9%-17.6%
Q2 2020+6.0%+0.1%+12.2%
Q4 2020+12.5%+8.9%+18.4%
Q3 2020+5.5%+29.6%+8.4%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro